Acelyrin Inc (SLRN)
4.24
0.00 (0.00%)
USD |
NASDAQ |
Apr 26, 16:00
4.235
0.00 (0.00%)
After-Hours: 20:00
Acelyrin Shareholders Equity (Quarterly): 656.34M for Dec. 31, 2023
Shareholders Equity (Quarterly) Chart
Historical Shareholders Equity (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 656.34M |
| September 30, 2023 | 732.38M |
| June 30, 2023 | 801.07M |
| Date | Value |
|---|---|
| March 31, 2023 | -143.35M |
| December 31, 2022 | -102.86M |
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
-143.35M
Minimum
Mar 2023
801.07M
Maximum
Jun 2023
388.71M
Average
656.34M
Median
Dec 2023
Shareholders Equity (Quarterly) Benchmarks
| Lexicon Pharmaceuticals Inc | 93.11M |
| Eagle Pharmaceuticals Inc | 252.04M |
| Avalo Therapeutics Inc | 7.304M |
| Design Therapeutics Inc | 277.69M |
| CEL-SCI Corp | 12.65M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 742.69M |
| Total Liabilities (Quarterly) | 86.35M |